CLINICAL TRIAL / NCT01357668

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

  • Observational
  • Recruiting
  • NCT01357668

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.